Skip to main content
Veterinary Medicines

NEOPURDOX 1000 MG/G

Authorised
  • NEOMYCIN SULFATE

Product identification

Medicine name:
NEOPURDOX 1000 MG/G
Active substance:
  • NEOMYCIN SULFATE
Target species:
  • Chicken (layer hen)
  • Sheep (lamb)
  • Turkey
  • Chicken
  • Cattle (calf)
  • Pig
Route of administration:
  • In drinking water/milk use
  • In drinking water use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water/milk use
    • Chicken (layer hen)
      • Meat and offal
        7
        day
    • Sheep (lamb)
      • Meat and offal
        14
        day
  • In drinking water use
    • Turkey
      • Meat and offal
        7
        day
    • Chicken (layer hen)
      • Eggs
        0
        day
    • Chicken
      • Meat and offal
        7
        day
    • Cattle (calf)
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07AA01
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dox-al Italia S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dox-Al Italia S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."